Retatrutide (30mg)

Retatrutide Australia Buy Extended-Protocol Triple-Agonist Vial (30mg)

Retatrutide Australia Buy  (30mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

The 30mg vial supports extended Retatrutide research protocols. At a standard 2mg weekly application, 30mg covers approximately 15 weeks of uninterrupted research from a single batch-verified vial.

Phase 2 clinical trials reported a mean body weight reduction of up to 24% over 48 weeks — outperforming semaglutide and tirzepatide in head-to-head comparisons. Retatrutide’s triple-receptor activity targets three pathways simultaneously: appetite regulation via GLP-1, fat metabolism and insulin sensitivity via GIP, and increased energy expenditure via glucagon receptor activation.

Key Research Areas

• Fat Loss Research — including visceral adiposity, across extended protocols
• Appetite Regulation — sustained food intake reduction over multi-month research windows
• Cardiometabolic Markers — blood pressure, LDL cholesterol, waist circumference
• Energy Expenditure — via glucagon receptor activation
• Comparative Research — outperforms semaglutide and tirzepatide in head-to-head data

Supplied as lyophilized powder at ≥99% purity, verified by HPLC and mass spectrometry. 30mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.